These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 15956157)

  • 41. High performance of cerebrospinal fluid immunoglobulin G analysis for diagnosis of multiple sclerosis.
    Gamraoui S; Mathey G; Debouverie M; Malaplate C; Anxionnat R; Guillemin F; Epstein J
    J Neurol; 2019 Apr; 266(4):902-909. PubMed ID: 30707357
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and diagnostic aspects of multiple sclerosis and acute monophasic encephalomyelitis in pediatric patients: a single centre prospective study.
    Atzori M; Battistella PA; Perini P; Calabrese M; Fontanin M; Laverda AM; Suppiej A; Drigo P; Grossi P; Rinaldi L; Gallo P
    Mult Scler; 2009 Mar; 15(3):363-70. PubMed ID: 18987105
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multiphasic acute disseminated encephalomyelitis or pediatric multiple sclerosis: report of an atypical case.
    Suppiej A; Manara R; De Palma L; De Grandis D; Citton V; Battistella PA
    J Child Neurol; 2009 Feb; 24(2):241-6. PubMed ID: 19182166
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The contribution of cerebrospinal fluid oligoclonal bands to the early diagnosis of multiple sclerosis.
    Zipoli V; Hakiki B; Portaccio E; Lolli F; Siracusa G; Giannini M; Pantoni L; Pescini F; Sorbi S; Amato MP
    Mult Scler; 2009 Apr; 15(4):472-8. PubMed ID: 19153171
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Spinal-cord MRI in multiple sclerosis: conventional and nonconventional MR techniques.
    Bot JC; Barkhof F
    Neuroimaging Clin N Am; 2009 Feb; 19(1):81-99. PubMed ID: 19064202
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early relapse risk after a first CNS inflammatory demyelination episode: examining international consensus definitions.
    Dale RC; Pillai SC
    Dev Med Child Neurol; 2007 Dec; 49(12):887-93. PubMed ID: 18039234
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostic value of paraclinical tests in multiple sclerosis: relative sensitivities and specificities for reclassification according to the Poser committee criteria.
    Beer S; Rösler KM; Hess CW
    J Neurol Neurosurg Psychiatry; 1995 Aug; 59(2):152-9. PubMed ID: 7629529
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increasing benefit of magnetic resonance imaging in multiple sclerosis.
    Pyhtinen J; Karttunen A; Tikkakoski T
    Acta Radiol; 2006 Nov; 47(9):960-71. PubMed ID: 17077049
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment optimisation in multiple sclerosis.
    Zaffaroni M
    Neurol Sci; 2005 Dec; 26 Suppl 4():S187-92. PubMed ID: 16388356
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Optimizing detection of oligoclonal bands in cerebrospinal fluid by use of isoelectric focusing with IgG immunoblotting.
    Keren DF
    Am J Clin Pathol; 2003 Nov; 120(5):649-51. PubMed ID: 14608888
    [No Abstract]   [Full Text] [Related]  

  • 51. Rituximab in a patient with multiple sclerosis--effect on B cells, plasma cells and intrathecal IgG synthesis.
    Petereit HF; Moeller-Hartmann W; Reske D; Rubbert A
    Acta Neurol Scand; 2008 Jun; 117(6):399-403. PubMed ID: 18031564
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recommendations for diagnosis and management of multiple sclerosis.
    Kes VB; Zavoreo I; Serić V; Solter VV; Cesarik M; Hajnsek S; Pasić MB; Gabelić T; Silvio B; Butković SS; Lusić I; Grbelja LD; Vladić A; Bielen I; Antoncić I; Demarin V; ; ;
    Acta Clin Croat; 2012 Mar; 51(1):117-35. PubMed ID: 22920014
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Neurofilament protein light in multiple sclerosis].
    Zhang Y; Li X; Qiao J
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2745-9. PubMed ID: 18167263
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CSF testing for multiple sclerosis.
    Pender MP
    Lancet Neurol; 2005 Sep; 4(9):522-3. PubMed ID: 16109359
    [No Abstract]   [Full Text] [Related]  

  • 55. Tau protein, phosphorylated tau protein and beta-amyloid42 in the cerebrospinal fluid of multiple sclerosis patients.
    Valis M; Talab R; Stourac P; Andrys C; Masopust J
    Neuro Endocrinol Lett; 2008 Dec; 29(6):971-6. PubMed ID: 19112391
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis.
    Rentzos M; Cambouri C; Rombos A; Nikolaou C; Anagnostouli M; Tsoutsou A; Dimitrakopoulos A; Triantafyllou N; Vassilopoulos D
    J Neurol Sci; 2006 Feb; 241(1-2):25-9. PubMed ID: 16316662
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multifocal visual evoked potential analysis of inflammatory or demyelinating optic neuritis.
    Fraser CL; Klistorner A; Graham SL; Garrick R; Billson FA; Grigg JR
    Ophthalmology; 2006 Feb; 113(2):323.e1-323.e2. PubMed ID: 16406544
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Laboratory diagnosis of multiple sclerosis. Elevation of immunoglobulin G in cerebrospinal fluid.
    Perry JJ; Hackett TN; Bray PF; Greene H; Jarcho LW
    Rocky Mt Med J; 1973 Jul; 70(7):42-4. PubMed ID: 4197762
    [No Abstract]   [Full Text] [Related]  

  • 59. [The latest world standards in the diagnosis of multiple sclerosis].
    Obuchowska I; Mariak Z
    Klin Oczna; 2009; 111(1-3):70-4. PubMed ID: 19517851
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oligoclonal bands measured in unconcentrated cerebrospinal fluid and other biochemical parameters in multiple sclerosis.
    Kurzepa J; Nastaj M; Mitosek-Szewczyk K; Bartosik-Psujek H; Stelmasiak Z
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):392-6. PubMed ID: 16146115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.